David Windley
Stock Analyst at Jefferies
(3.64)
# 790
Out of 5,050 analysts
204
Total ratings
67.26%
Success rate
14.35%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Buy | $317 → $409 | $324.21 | +26.15% | 27 | Oct 17, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $400 → $450 | $589.15 | -23.62% | 6 | Sep 9, 2025 | |
| IQV IQVIA Holdings | Upgrades: Buy | $195 → $225 | $210.46 | +6.91% | 5 | Sep 9, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Hold | $220 → $175 | $159.14 | +9.97% | 15 | Sep 9, 2025 | |
| FTRE Fortrea Holdings | Maintains: Hold | $7 → $9.5 | $11.25 | -15.56% | 3 | Sep 9, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $142 → $195 | $168.05 | +16.04% | 20 | Sep 9, 2025 | |
| STE STERIS | Initiates: Hold | $263 | $263.77 | -0.29% | 1 | May 29, 2025 | |
| SLQT SelectQuote | Initiates: Hold | $2.75 | $1.73 | +58.96% | 1 | May 21, 2025 | |
| CNC Centene | Maintains: Hold | $64 → $61 | $37.56 | +62.41% | 28 | Apr 29, 2025 | |
| OSCR Oscar Health | Initiates: Underperform | $12 | $17.72 | -32.28% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $419 → $253 | $252.04 | +0.38% | 18 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $402 → $422 | $264.58 | +59.50% | 17 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $297 | $152.06 | +95.32% | 23 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $3.75 | $1.16 | +223.28% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $317.78 | +90.07% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $560.00 | -33.04% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $15.68 | -1.15% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $294.86 | -8.43% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $8.67 | +78.78% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $271.04 | +97.76% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $24.10 | +20.33% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $7.53 | +3,193.49% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $107 → $110 | $92.31 | +19.16% | 7 | Oct 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.35 | - | 5 | Oct 9, 2017 |
UnitedHealth Group
Oct 17, 2025
Maintains: Buy
Price Target: $317 → $409
Current: $324.21
Upside: +26.15%
Medpace Holdings
Sep 9, 2025
Maintains: Hold
Price Target: $400 → $450
Current: $589.15
Upside: -23.62%
IQVIA Holdings
Sep 9, 2025
Upgrades: Buy
Price Target: $195 → $225
Current: $210.46
Upside: +6.91%
ICON Public Limited Company
Sep 9, 2025
Downgrades: Hold
Price Target: $220 → $175
Current: $159.14
Upside: +9.97%
Fortrea Holdings
Sep 9, 2025
Maintains: Hold
Price Target: $7 → $9.5
Current: $11.25
Upside: -15.56%
Charles River Laboratories International
Sep 9, 2025
Upgrades: Buy
Price Target: $142 → $195
Current: $168.05
Upside: +16.04%
STERIS
May 29, 2025
Initiates: Hold
Price Target: $263
Current: $263.77
Upside: -0.29%
SelectQuote
May 21, 2025
Initiates: Hold
Price Target: $2.75
Current: $1.73
Upside: +58.96%
Centene
Apr 29, 2025
Maintains: Hold
Price Target: $64 → $61
Current: $37.56
Upside: +62.41%
Oscar Health
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $17.72
Upside: -32.28%
Oct 7, 2024
Downgrades: Hold
Price Target: $419 → $253
Current: $252.04
Upside: +0.38%
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $264.58
Upside: +59.50%
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $152.06
Upside: +95.32%
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $1.16
Upside: +223.28%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $317.78
Upside: +90.07%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $560.00
Upside: -33.04%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $15.68
Upside: -1.15%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $294.86
Upside: -8.43%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $8.67
Upside: +78.78%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $271.04
Upside: +97.76%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $24.10
Upside: +20.33%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $7.53
Upside: +3,193.49%
Oct 30, 2017
Maintains: Hold
Price Target: $107 → $110
Current: $92.31
Upside: +19.16%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.35
Upside: -